Afuco™ Anti-Human HHLA2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-HHLA2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies capable of immunospecifically binding to the B7-H7 counter-receptor, H7CR are used in enhancing immune responses and the treatment and diagnosis of cancer and other diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-337CL |
| Pricing | Inquiry |
| Host | Human |
| Target | HHLA2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |